Compare ASH & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASH | PRVA |
|---|---|---|
| Founded | 1924 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2016 | 2021 |
| Metric | ASH | PRVA |
|---|---|---|
| Price | $57.23 | $22.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $65.57 | $31.17 |
| AVG Volume (30 Days) | 772.3K | ★ 862.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | N/A | ★ 63.64 |
| EPS | ★ 0.08 | 0.02 |
| Revenue | $1,824,000,000.00 | ★ $2,122,842,000.00 |
| Revenue This Year | $2.58 | $18.19 |
| Revenue Next Year | $4.28 | $10.72 |
| P/E Ratio | ★ $681.13 | $1,136.75 |
| Revenue Growth | N/A | ★ 22.26 |
| 52 Week Low | $46.30 | $18.78 |
| 52 Week High | $65.65 | $26.51 |
| Indicator | ASH | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 56.61 | 44.83 |
| Support Level | $53.89 | $22.63 |
| Resistance Level | $60.79 | $24.74 |
| Average True Range (ATR) | 2.42 | 0.91 |
| MACD | 0.18 | -0.24 |
| Stochastic Oscillator | 89.47 | 41.73 |
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.